Showing results (1161-1170 of 1,242) with videos related to

Sort By:
Pageof 125
Cytometry. Part B, Clinical Cytometry|December 29, 2020
Best practices for the development, analytical validation and clinical implementation of flow cytometric methods for chimeric antigen receptor T cell analysesGhanashyam Sarikonda, Mélissa Mathieu, Mahwish Natalia, et al.
Cytometry. Part B, Clinical Cytometry|December 28, 2020
Exploring blast composition in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms: CD45RA and CD371 improve diagnostic value of flow cytometry through assessment of myeloblast heterogeneity and stem cell aberrancyAfshin Shameli, Poonam Dharmani-Khan, Joanne Luider, et al.
Cytometry. Part B, Clinical Cytometry|December 28, 2020
ESCCA/ISCCA protocol for the analysis of cerebrospinal fluid by multiparametric flow-cytometry in hematological malignanciesMaria Ilaria Del Principe, Arianna Gatti, Ulrika Johansson, et al.
Cytometry. Part B, Clinical Cytometry|July 7, 2021
Time point-dependent concordance and prognostic significance of flow cytometry and real time quantitative PCR for measurable/minimal residual disease detection in acute myeloid leukemia with t(8;21)(q22;q22.1)Lei Shang, Xiaojin Cai, Wanchen Sun, et al.
Cytometry. Part B, Clinical Cytometry|October 28, 2020
International guidelines for the flow cytometric evaluation of peripheral blood for suspected Sézary syndrome or mycosis fungoides: Assay development/optimization, validation, and ongoing quality monitorsAndrea Illingworth, Ulrika Johansson, Shuguang Huang, et al.
Cytometry. Part B, Clinical Cytometry|February 4, 2020
Flow cytometric basophil activation tests: Staining of exteriorized basophil granule matrix by fluorescent avidin versus appearance of CD63Didier G Ebo, Jessy Elst, Michel van Houdt, et al.
Cytometry. Part B, Clinical Cytometry|May 6, 2008
Cytotoxicity and antibody binding by flow cytometry: a single assay to simultaneously assess two parametersChee L Saw, Robert A Bray, Howard M Gebel
Cytometry. Part B, Clinical Cytometry|June 13, 2008
Standardization of flow cytometric minimal residual disease evaluation in acute lymphoblastic leukemia: Multicentric assessment is feasibleMichael Norbert Dworzak, Giuseppe Gaipa, Richard Ratei, et al.
Cytometry. Part B, Clinical Cytometry|October 1, 2019
Flow Cytometric Immunophenotypic Analysis in the Diagnosis and Prognostication of Plasma Cell NeoplasmsHao-Wei Wang, Pei Lin
Cytometry. Part B, Clinical Cytometry|October 2, 2019
Flow cytometric features of incidental indolent T lymphoblastic proliferationsJonathan R Fromm, Kerstin L Edlefsen, Sindhu Cherian, et al.
Pageof 125